THIS AGREEMENT is made and entered into this 5th day of March, 1999, by and between AIDS
RESEARCH Alliance (ALLIANCE), a California nonprofit public benefit corporation having an office at 621A
North San Vicente Boulevard, West Hollywood, California 90069, and Steroidogenesis Inhibitors International
Corporation (SII), a Nevada corporation having an office at 2001 E. Flamingo Road, Suite 100-B, Las Vegas.
This agreement is intended to enable Alliance and SII to obtain an initial evaluation, through a trial to be
conducted by Alliance in accordance with a protocol that has been approved by both parties, of the positive and
negative effects on human subjects of an experimental drug developed by SII and known as Anticort. SII will
provide sufficient quantities of Anticort for the trial. Alliance will conduct and compile the results of the trial in
accordance with this agreement and the protocol.
II. Anticort Trial Protocol
The Anticort trial shall be conducted in accordance with this agreement and the protocol (the Protocol) approved
by both Alliance and SII attached as Exhibit A hereto. No modification, revision or amendment to the Protocol
shall be valid or effective for any purpose unless in writing and duly executed by both Alliance and SII in the same
manner as the Protocol attached as Exhibit A hereto.
III. Delivery of Anticort
Throughout the course of the trial, SII shall deliver to Alliance such quantities of Anticort as are, in the judgment
of Alliance, sufficient to enable Alliance to conduct the trial in accordance with the Protocol. All Anticort
delivered to Alliance shall have been manufactured, finished and filled in accordance with the Good
Manufacturing Practice regulations promulgated by the United States Food and Drug Administration in Title 21 of
the Code of Federal Regulations, and packaged in a condition that permits consumption by humans in
accordance with all applicable laws and regulations of the State of California.